Deep deletions were significantly more prevalent in prostate cancer than in breast cancer, with frequent occurrences in ABCG2, ABCG1, ABCC4, ABCA2, ABCC2, ABCC7/CFTR, and ABCC9. This evidence concerns the gene ABCA2 and prostate carcinoma.